Skip to main content
Equibles

Alex Shvartsburg

CFO

LivaNova PLC (LIVN)

Equibles does not estimate personal net worth.

Get an email with a short summary when LivaNova PLC publishes a filing, an earnings call transcript or a press release.

Get LIVN alerts

About Alex Shvartsburg

Alex Shvartsburg is recorded as CFO at LivaNova PLC (LIVN). The newest filing on record that lists Alex Shvartsburg as CFO at LivaNova PLC (LIVN) is dated April 29, 2026. The proxy statement of LivaNova PLC reports total compensation of $2,771,180 for Alex Shvartsburg in fiscal 2023, including a base salary of $536,885. Disclosed compensation is on record for 4 fiscal years. Alex Shvartsburg has spoken on 23 earnings calls and 2 other investor events across 1 company, most recently for LivaNova PLC on September 15, 2026. LivaNova PLC is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at LivaNova PLC includes Vladimir A. Makatsaria (CEO and Board Member), Vladimir Makatsaria (CEO and Board Member), William A. Kozy (CEO and Board Member) and 7 others.

Alex Shvartsburg on recent calls

“So when you think about the pace of top-line growth versus the earnings growth of the leverage that you have through the 28 period, is it also fair to assume that maybe there's some conservatism baked into that as much as we assume there has been on the on the top line well i think just generally speaking we have two…”
CFO, Baird 2026 Global Healthcare Conference ·
“During my portion of the call, I'll share a brief recap of the second quarter results and provide commentary on our updated full year 2026 guidance, which reflects strong performance year to date and improved business outlook.”
CFO, 2Q 2026 LivaNova PLC Earnings Conference Call ·
“Well, let me start off by saying our capital allocation strategy hasn't changed since Investor Day. Our clearest line of sight to value creation continues to be our core, as Vlad mentioned, so we're going to continue to invest in that.”
CFO, Goldman Sachs 47th Annual Global Healthcare Conference ·
“So, in the subset that we track, we're not going to have any patients that have been denied access to VNS therapy.”
CFO, LivaNova PLC Q1 FY2026 Earnings Call ·
“During my portion of the call, I will share a brief recap of the fourth quarter results and provide commentary on 2026 guidance. Turning to results. Revenue in the quarter was $361 million, an increase of 9.5% on a constant currency and organic basis versus the prior year.”
CFO, LivaNova PLC Q4 FY2025 Earnings Call ·

Affiliation history

  • LivaNova PLC (LIVN)

    CFO

    Proxy statement

    Current

    Start not stated–present

    Last confirmed April 29, 2026

Company network

Leadership on record at LivaNova PLC

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 LivaNova PLC (LIVN) $536,885 $2,771,180
2022 LivaNova PLC (LIVN) $434,231 $2,128,666
2021 LivaNova PLC (LIVN) $431,476 $2,029,359
2020 LivaNova PLC (LIVN) $321,104 $1,141,029

Recent activity

Show 13 earlier activities